Programma van 25 oktober
Het [URL="http://www.professionalabstracts.com/ec ... ms2017.pdf"][U]programma[/U][/URL] van vandaag (klik op de link voor de individuele bijdragen):
08:30 - 10:00 Teaching Course 1: Disease modifying treatment
08:30 - 10:00 Teaching Course 2: MS and reproduction: from
contraception to post conception reproductive epidemiology and planning a pregnancy in women with MS
08:30 - 10:00 Teaching Course 5: Biomarkers in MS
08:30 - 10:00 Teaching Course 4: Myelin repair: scientific background and clinical implications
08:30 - 10:00 Teaching Course 3: Advanced MS genetics and immunology
10:30 - 12:00 Teaching Course 6: Controversy in management
10:30 - 12:00 Teaching Course 7: Symptomatic therapy of gait disturbances, spasticity, bladder dysfunction and paroxysmal symptoms
10:30 - 12:00 Teaching Course 8: Brain atrophy in clinical practice: evidence base and barriers to implementation
Met Barkhof:
Natural history & clinical relevance of brain volume changes in patients with MS - F. Barkhof (Amsterdam, NL)
10:30 - 12:00 Teaching Course 9: Cognition
10:30 - 12:00 Teaching Course 10: Progressive multiple sclerosis and the relationship to relapsing disease - how neuroglial interactions underlie the pathogenesis and treatment
12:30 - 13:30 European Charcot Foundation - Reconsidering the concept of induction therapy
12:30 - 14:00 Teaching Course 11: Differential diagnoses
12:30 - 14:00 Teaching Course 12: Neuromyelitis optica spectrum
disorders
12:30 - 14:00 Teaching Course 13: Imaging the non-MS lesion in MS
12:30 - 14:00 Teaching Course 14: OCT in clinical practice
12:30 - 14:00 Case-based Teaching Course 15: Paediatric MS
14:00 - 15:30 Parallel Session 1: Prevalence and phenotype evolution of MS in different continents
14:00 - 15:30 Young Scientific Investigators' Session 1
Met onderzoek van de VU:
Altered default-mode network dynamics in cognitively impaired MS
patients - A.J. Eijlers (Amsterdam, NL)
14:15 - 15:30 Nurses' Session 1: Impact of MS nursing across Europe
14:15 - 15:45 Case-based Teaching Course 16: Induction treatment in very active multiple sclerosis: why, how, when?
14:15 - 15:45 Case-based Teaching Course 17: Definition of nonresponders
14:15 - 15:45 Case-based Teaching Course 18: Progressive MS: whom to treat, with what and for how long?
16:00 - 16:45 Hot Topic 1: Progressive MS alliance: what’s new
16:00 - 17:15 Young Scientific Investigators' Session 2
16:00 - 16:45 Hot Topic 2: e-MS and patients related outcomes
16:00 - 17:15 Nurses' Session 2: Nurses leading the translation of research into practice
17:30 - 18:30 Satellite Symposium - Navigating choice. Can real world evidence (RWE) deliver personalised medicine?
ECTRIMS - MS Congres
-
Marsei
Programma van 26 oktober
Programma van 26 oktober
07:45 - 08:45 Satellite Symposium - New horizons in progressive multiple sclerosis
09:00 - 10:15 Plenary Session 1 - Welcome and ECTRIMS-ACTRIMS
Lecture
10:45 - 12:15 Parallel Session 2: The new MS criteria
10:45 - 12:15 Parallel Session 3: Update on MS prognostic markers
10:45 - 12:15 Parallel Session 4: Axon/myelin injury in MS lesions and experimental models
10:45 - 12:15 Parallel Session 5: The blood brain barriers in MS
12:45 - 13:45 Satellite Symposium - Beyond the lightbulb: exploring the known unknown
12:45 - 13:45 Satellite Symposium - Emerging landscape of the next
generation of MS therapies: current efforts in remyelination and neurorestoration
14:00 - 15:30 Parallel Session 6: Therapeutic perspectives in
progressive MS
14:00 - 15:30 Parallel Session 7: Paediatric MS
14:00 - 15:30 Parallel Session 8: Immune cells in injury and repair
14:00 - 15:30 Parallel Session 9: New insight into grey matter pathology in MS
Zie voor de [URL="http://www.professionalabstracts.com/ec ... ms2017.pdf"][U]poster sessie[/U][/URL] p. 19 t/m p. 57
15:45 - 16:45 Burning Debate - Rumble in the jungle: B cells vs. T cells
17:00 - 17:45 Hot Topic 3: Controversy 1: RIS: should it be treated?
17:00 - 17:45 Hot Topic 4: New insight in neurobiology / how the active brain stimulates repair?
17:00 - 17:45 Hot Topic 5: Cognition and cognitive remediation in MS
17:00 - 17:45 Hot Topic 6: Gut microbiota in multiple sclerosis
18:00 - 19:00 Satellite Symposium - Balancing benefits and risks of
DMDs in MS
19:15 - 20:15 Satellite Symposium - Navigating choice. Mastering the multiple facets of MS management
07:45 - 08:45 Satellite Symposium - New horizons in progressive multiple sclerosis
09:00 - 10:15 Plenary Session 1 - Welcome and ECTRIMS-ACTRIMS
Lecture
10:45 - 12:15 Parallel Session 2: The new MS criteria
10:45 - 12:15 Parallel Session 3: Update on MS prognostic markers
10:45 - 12:15 Parallel Session 4: Axon/myelin injury in MS lesions and experimental models
10:45 - 12:15 Parallel Session 5: The blood brain barriers in MS
12:45 - 13:45 Satellite Symposium - Beyond the lightbulb: exploring the known unknown
12:45 - 13:45 Satellite Symposium - Emerging landscape of the next
generation of MS therapies: current efforts in remyelination and neurorestoration
14:00 - 15:30 Parallel Session 6: Therapeutic perspectives in
progressive MS
14:00 - 15:30 Parallel Session 7: Paediatric MS
14:00 - 15:30 Parallel Session 8: Immune cells in injury and repair
14:00 - 15:30 Parallel Session 9: New insight into grey matter pathology in MS
Zie voor de [URL="http://www.professionalabstracts.com/ec ... ms2017.pdf"][U]poster sessie[/U][/URL] p. 19 t/m p. 57
15:45 - 16:45 Burning Debate - Rumble in the jungle: B cells vs. T cells
17:00 - 17:45 Hot Topic 3: Controversy 1: RIS: should it be treated?
17:00 - 17:45 Hot Topic 4: New insight in neurobiology / how the active brain stimulates repair?
17:00 - 17:45 Hot Topic 5: Cognition and cognitive remediation in MS
17:00 - 17:45 Hot Topic 6: Gut microbiota in multiple sclerosis
18:00 - 19:00 Satellite Symposium - Balancing benefits and risks of
DMDs in MS
19:15 - 20:15 Satellite Symposium - Navigating choice. Mastering the multiple facets of MS management
-
Circle
Ectrims dag 1
Ectrims dag 1
Even een update van ectrims dag 1. Geweldig om 10000 onderzoekers/artsen en hun onderzoeken hier samen te zien. Er zijn zo veel presentaties dat het onmogelijk is om alles te volgen. Ik probeer highlights te tweeten, en hoor ook veel dingen waarvan ik denk daar moet ik nog eens even induiken. Er is heel veel ook terug te vinden via de ectrims website. De eerste dag vond ik de sessies over het concept inductietherapie en over nieuwe beeldvormende technieken erg de moeite waard. Ik ga zo richting palais des congres om om 9.00 de officiele openingslezing bij te wonen.
Even een update van ectrims dag 1. Geweldig om 10000 onderzoekers/artsen en hun onderzoeken hier samen te zien. Er zijn zo veel presentaties dat het onmogelijk is om alles te volgen. Ik probeer highlights te tweeten, en hoor ook veel dingen waarvan ik denk daar moet ik nog eens even induiken. Er is heel veel ook terug te vinden via de ectrims website. De eerste dag vond ik de sessies over het concept inductietherapie en over nieuwe beeldvormende technieken erg de moeite waard. Ik ga zo richting palais des congres om om 9.00 de officiele openingslezing bij te wonen.
-
MSweb
-
Marsei
Programma van 27 oktober
Programma van 27 oktober
08:00 - 09:00 Satellite Symposium - Providing solutions to treatment
burden in MS
09:15 - 10:15 Free Communications 1
09:15 - 10:15 Free Communications 2
Met oa I. Huitinga (Amsterdam, NL) - Lesion activity relates to clinical course and gender in the multiple sclerosis autopsy cohort of the Netherlands Brain Bank
09:15 - 10:15 Free Communications 3
09:15 - 10:15 Free Communications 4
10:45 - 12:15 Parallel Session 10: Safety issues in MS therapeutic
management
10:45 - 12:15 Parallel Session 11: Genes and environment in MS
10:45 - 12:15 Parallel Session 12: Long term disability evolution:
contributions from cohorts and clinical trials
12:45 - 13:45 Satellite Symposium - The evolution of MS treatment:
moving towards optimised treatments
12:45 - 13:45 Satellite Symposium - Maintaining ability in the context of disability: can we do more for patients?
14:00 - 15:30 Parallel Session 13: Update on relapsing-remitting MS
management
14:00 - 15:30 Parallel Session 14: Remyelination: from biology to clinical trials
14:00 - 15:30 Parallel Session 15: Metabolic and molecular imaging of MS
[URL="http://www.professionalabstracts.com/ec ... ms2017.pdf"][U]Poster Session 2[/U][/URL] (p 68 t/m p 103)
15:45 - 16:45 Google Hangout - Online hangout with MS community
17:00 - 17:45 Hot Topic 7: Controversy 2: Anti-MOG disease: a new
entity different from NMO spectrum disorder?
17:00 - 17:45 Hot Topic 8: Aging with MS
17:00 - 17:45 Hot Topic 9: Immune cells on the move
17:00 - 17:45 Hot Topic 10: Insight from new imaging methods
18:00 - 19:00 Satellite Symposium - Turning the lights on: seeing is
believing
19:15 - 20:15 Satellite Symposium - From days to decades: providing for patients throughout the MS disease course
08:00 - 09:00 Satellite Symposium - Providing solutions to treatment
burden in MS
09:15 - 10:15 Free Communications 1
09:15 - 10:15 Free Communications 2
Met oa I. Huitinga (Amsterdam, NL) - Lesion activity relates to clinical course and gender in the multiple sclerosis autopsy cohort of the Netherlands Brain Bank
09:15 - 10:15 Free Communications 3
09:15 - 10:15 Free Communications 4
10:45 - 12:15 Parallel Session 10: Safety issues in MS therapeutic
management
10:45 - 12:15 Parallel Session 11: Genes and environment in MS
10:45 - 12:15 Parallel Session 12: Long term disability evolution:
contributions from cohorts and clinical trials
12:45 - 13:45 Satellite Symposium - The evolution of MS treatment:
moving towards optimised treatments
12:45 - 13:45 Satellite Symposium - Maintaining ability in the context of disability: can we do more for patients?
14:00 - 15:30 Parallel Session 13: Update on relapsing-remitting MS
management
14:00 - 15:30 Parallel Session 14: Remyelination: from biology to clinical trials
14:00 - 15:30 Parallel Session 15: Metabolic and molecular imaging of MS
[URL="http://www.professionalabstracts.com/ec ... ms2017.pdf"][U]Poster Session 2[/U][/URL] (p 68 t/m p 103)
15:45 - 16:45 Google Hangout - Online hangout with MS community
17:00 - 17:45 Hot Topic 7: Controversy 2: Anti-MOG disease: a new
entity different from NMO spectrum disorder?
17:00 - 17:45 Hot Topic 8: Aging with MS
17:00 - 17:45 Hot Topic 9: Immune cells on the move
17:00 - 17:45 Hot Topic 10: Insight from new imaging methods
18:00 - 19:00 Satellite Symposium - Turning the lights on: seeing is
believing
19:15 - 20:15 Satellite Symposium - From days to decades: providing for patients throughout the MS disease course
-
Circle
ectrims
ectrims
Dag 3 is net begonnen, weer met een satellite van Merck over cladribine (Mavenclad). (Het wachtwoord voor de wifi tijdens msparis2017 is ook MAVENCLAD4MS). Elke dag weer heel lastig om te kiezen uit het enorme programma. Ik heb vandaag gekozen voor free comunications 2 met Frederik Barkhof, parallel sessie genes and environment, dan the evolution of MS treatment, update on relapsing remitting MS management, de google hangout is te volgen via you tube, aging with MS en daarna waarschijnlijk beide satellite symposia. Tot nu toe elke dag al afgeweken van mijn vooraf bedachte plan.
Dag 3 is net begonnen, weer met een satellite van Merck over cladribine (Mavenclad). (Het wachtwoord voor de wifi tijdens msparis2017 is ook MAVENCLAD4MS). Elke dag weer heel lastig om te kiezen uit het enorme programma. Ik heb vandaag gekozen voor free comunications 2 met Frederik Barkhof, parallel sessie genes and environment, dan the evolution of MS treatment, update on relapsing remitting MS management, de google hangout is te volgen via you tube, aging with MS en daarna waarschijnlijk beide satellite symposia. Tot nu toe elke dag al afgeweken van mijn vooraf bedachte plan.
-
Leonard
-
Circle
-
Marsei
Super Linda! Ik ben wel benieuwd naar blok over darmflora waar je geweest was:
Hot Topic 6: Gut microbiota in multiple sclerosis
Misschien kun je nog iets meer vertellen over het onderzoek van Inge Huitinga:
[QUOTE]Zeer interessante presentatie van Inge Huitinga van de Nederlandse Hersenbank over de resultaten van post mortem weefselonderzoek bij MS patienten. 76% had chronisch actieve laesies en 57% van alle laesies was chronisch actief.[/QUOTE]
Hot Topic 6: Gut microbiota in multiple sclerosis
Misschien kun je nog iets meer vertellen over het onderzoek van Inge Huitinga:
[QUOTE]Zeer interessante presentatie van Inge Huitinga van de Nederlandse Hersenbank over de resultaten van post mortem weefselonderzoek bij MS patienten. 76% had chronisch actieve laesies en 57% van alle laesies was chronisch actief.[/QUOTE]